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Abstract
Background: Membrane proteins are privileged pharmaceutical targets for which the development of structure-based drug
design is challenging. One underlying reason is the fact that detergents do not stabilize membrane domains as efficiently as
natural lipids in membranes, often leading to a partial to complete loss of activity/stability during protein extraction and
purification and preventing crystallization in an active conformation.
Methodology/Principal Findings: Anionic calix[4]arene based detergents (C4Cn, n=1–12) were designed to structure the
membrane domains through hydrophobic interactions and a network of salt bridges with the basic residues found at the
cytosol-membrane interface of membrane proteins. These compounds behave as surfactants, forming micelles of 5–24 nm,
with the critical micellar concentration (CMC) being as expected sensitive to pH ranging from 0.05 to 1.5 mM. Both by
1H
NMR titration and Surface Tension titration experiments, the interaction of these molecules with the basic amino acids was
confirmed. They extract membrane proteins from different origins behaving as mild detergents, leading to partial extraction
in some cases. They also retain protein functionality, as shown for BmrA (Bacillus multidrug resistance ATP protein), a
membrane multidrug-transporting ATPase, which is particularly sensitive to detergent extraction. These new detergents
allow BmrA to bind daunorubicin with a Kd of 12 mM, a value similar to that observed after purification using dodecyl
maltoside (DDM). They preserve the ATPase activity of BmrA (which resets the protein to its initial state after drug efflux)
much more efficiently than SDS (sodium dodecyl sulphate), FC12 (Foscholine 12) or DDM. They also maintain in a functional
state the C4Cn-extracted protein upon detergent exchange with FC12. Finally, they promote 3D-crystallization of the
membrane protein.
Conclusion/Significance: These compounds seem promising to extract in a functional state membrane proteins obeying
the positive inside rule. In that context, they may contribute to the membrane protein crystallization field.
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Introduction
Membrane proteins represent 20–30% of total proteins in all
species [1] and up to 60% of pharmaceutical targets [2]. However,
as of today, only 1% have been structurally characterized [3],
seriously compromising structure-based drug design. Several
difficulties hinder structural studies of membrane proteins [4].
They are generally not abundantly expressed in cells and are
refractory to overexpression, especially for eukaryotic proteins [5].
The major bottleneck for their crystallization arises from their
instability outside a lipid bilayer environment. To be purified, they
first need to be extracted by detergents, forming complex micelles
where looser packing can lead to unfolding and loss of activity [6].
Micelle-forming detergents are also well known for their ability to
reduce protein-protein contacts and consequently the probability
of protein crystallization. Several alternatives have been proposed
such as amphipols, large polymers that efficiently stabilize
membrane proteins by surrounding their lipophilic domain but
remain poor detergents [7,8]. Peptide-like detergents such as
lipopeptides have also been developed to mimic membrane
domains [9]. Maltoside cholane derivatives have been conceived
to cover large stretches of membrane domains [10]. More recently
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to stabilize integral membrane proteins [11]. All these solutions,
although elegant, yet have not significantly opened up the field. In
the present work, we have designed a new generation of
detergents. They have been conceived for increasing the stability
of the extracted/purified membrane protein by maintaining a
higher rigidity of the membrane domain than that obtained by
classical detergents, and closer to that imposed by lipids in a
bilayer membrane environment. We have demonstrated the utility
of these compounds by extracting different membrane proteins
from prokaryote to higher eukaryote cell lines. Moreover, these
compounds increased the stability of one membrane protein,
BmrA, which was demonstrated to be maintained in its active state
during extraction and purification, even after detergent exchange,
and finally promoting its 3D crystallization.
Materials and Methods
C4Cn stock solution preparation
Compounds were prepared at 10 mg/ml in water, buffered to
pH 8.0 (or 6 to 9 when indicated) with NaOH/HCl, the final salt
concentration being adjusted to 0.3 M.
Surface tension measurements
Surface tension properties of C4Cn were determined on a 1-ml
drop using a Kibron m-Trough and with a stainless steel needle in
the Wilhemy balance. Curves were fitted with Sigmaplot v11.
CMC values were calculated from the resulting plots as the
intersection between the plateau reached at the minimal value of
the surface tension and the tangent of each curve.
Dynamic light scattering (DLS)
C4Cn suspensions were diluted to 10 mM, sonicated for 1 min
(10 on/off cycles of 3 sec) and centrifuged for 1 h at 100,000 g
prior to determination of the apparent dynamic radius on a
Zetasizer NanoS apparatus (Malvern), measurements were
repeated six times. The mean size distribution was generated as
an intensity distribution then converted to a volume distribution
and a number distribution using the DTS software v5.0.
NMR
1H NMR spectra of 10 mM of the respective amino acids
(99%+, ACROS) prepared in D2O were recorded on a Bruker
Avance II-200 (500.13 MHz for
1H) spectrometer equipped with a
BBO BB-1H/D Z-GRD direct broad-band probe. C4C1 was
prepared as above, but with NaOD, DCl and D2O.
1H NMR
titration experiments were carried out by varying the amino acid
to C4C1 ratio from 0.1 to 20.
Protein expressions and membrane preparations
ABC transporter enriched-membranes were prepared as
described, for BmrA [12] and YheI/YheH (a Bacillus subtilis
ABC transporter) [13] expressed in E. coli, whereas BCRP was
expressed in either Spodoptera frugiperda (Sf9) insect cells [14] or
human embryonic kidney (HEK293) cells [15]. Membrane
fraction from HEK293 cells was prepared as follows: cells were
incubated for 1 h in a hypotonic buffer containing 10 mM Tris-
HCl pH 8.0, 10 mM KCl, 5 mM EDTA and supplemented with
protease inhibitors (Sigma). Crude membranes were prepared by
homogenizing cells with a Potter-Elvehjem homogenizer (Fisher
Scientific Bioblock). Unbroken cells were removed by centrifuga-
tion at 1000 g for 15 min at 4uC. The supernatant was then
centrifuged for 10 min at 10,000 g at 4uC, and then for 1 h at
100,000 g, at 4uC to pellet membranes. Membrane fractions were
suspended at about 20 mg/ml before storage at 280uC in either
20 mM Tris-HCl, 1 mM EDTA, 0.3 M sucrose for BmrA or
YheI/YheH, and 10 mM Hepes pH 8.0, 50 mM NaCl, 20%
glycerol, 0.1 mM DTT, 1 mM EDTA for BCRP. Membrane
fractions were analyzed on 10% SDS-PAGE (SDS polyacrylamide
gel electrophoresis) [16] and their protein content estimated by the
bicinchoninic acid method [17].
Extraction assays
Membranes were thawed, and solubilisation was carried out for
either 2 h (BmrA, BCRP) or 3 h (YheI/YheH) at 4uC with a
protein concentration of 2 mg/ml (BmrA, BCRP) or 1 mg/ml
(YheI/YheH). The C4Cn: protein ratio (w/w) was 5 (BmrA,
BCRP) or 10 (YheI/YheH) in 20 mM Tris-HCl pH 8.0, 0.1 M
NaCl (BmrA, BCRP) or 50 mM Tris-HCl pH 8.0, 15% glycerol,
100 mM NaCl, 10 mM imidazole, 5 mM b-mercaptoethanol
(YheI/YheH). When indicated, solubilisations were carried out
with DDM (Affimetrix) or FC12 (Affimetrix). Extracted and non-
extracted materials were then separated by centrifugation at
100,000 g for 1 h. BCRP was detected by Western-blot using the
BXP21 antibody (mouse, Millipore).
ATPase activity
The ATPase activity was measured by quantifying the inorganic
phosphate generated by ATP hydrolysis. Samples were incubated
20 min at 37uC in 50 mM Tris-HCl pH 8.0, 50 mM NaCl, 5 mM
ATP, 5 mM MgCl2, and 2 mM NaN3. Experiments were carried
out in the presence or absence of 1 mM orthovanadate to deduce
the vanadate sensitive ATPase activity for ABC transporters [18].
The reaction was stopped by addition of 10% SDS before
measuring the inorganic phosphate released [19].
Purification of ABC transporters with C4Cn
The MSSSHHHHHH sequence was introduced by PCR at the
59-end of the gene coding for BmrA, and cloned into the
expression plasmid pET15b (Novagen). The protein (H6BmrA)
was expressed in C41-DE3 E. coli strain and membrane fractions
prepared as described [20]. Five milligram (proteins) of BmrA-
enriched membranes were diluted to 2 mg/ml in 20 mM Tris-
HCl pH 8.0, 0.5 M NaCl, protease inhibitors cocktail (Roche) and
10 mg/ml C4C3 were added, followed by an incubation of 2 h at
4uC and by centrifugation (100,000 g for 1 h at 4uC). C4C7 was
added to the resulting supernatant at a concentration of 5 mg/ml,
and the solution was subjected to the same treatment as mentioned
above. The C4C7 supernatant was then analysed by DLS, as
described above, or used for affinity and gel filtration chromatog-
raphies as described below. The C4C7 supernatant was bound to
a nickel-nitriloacetic acid (NTA)-agarose resin of 1 ml (High Trap
chelating hp GE Healthcare), then washed with 15 ml of 20 mM
Tris-HCl pH 8.0, 0.5 M NaCl and 1 mg/ml C4C7. H6BmrA was
eluted with a gradient from 0 to 100% of 20 mM Tris-HCl
pH 8.0, 0.5 M NaCl, 250 mM imidazole and 1 mg/ml C4C7.
The elution fractions were pooled, concentrated to 0.5 ml on
Amicon Ultra4 50,000 (Millipore), loaded onto a Superdex 200
10/300 GL gel filtration resin (GE Healthcare) and eluted with
20 mM Tris-HCl pH 8.0, 0.1 M NaCl, 1 mg/ml FC12 as mobile
phase.
Fluorescence spectroscopy
Experiments were performed at room temperature using a
Photon Technology International Quanta Master I spectrofluo-
rimeter. All measurements were recorded in 500-mL quartz
cuvettes (Hellma) with a 0.5-cm path length. Data were corrected
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tested compounds by recording similar spectra with N-acetyl
tryptophanamide as a control (NATA). BmrA (1 mM) (solubilized
in FC12 or C4C10 and then purified with FC12) was in 20 mM
Tris-HCl pH 8.0, 50 mM NaCl, 3 mg/ml FC12, 0.02 mM
EDTA, 0.1 mM DTT and protease inhibitor cocktail. The
fluorescence excitation was set at 295 nm, and the fluorescence
emission scanned from 310 to 370 nm. The concentration-
dependent quenching studies for daunorubicin (0–40 mM) and
C4C10 (0–25 mM) were performed three times. Peak area of
corrected fluorescence spectra were fitted with the SigmaPlot
software (v11, Systat Software Inc.). Percentages of fluorescence
quenching were calculated as a protein/NATA ratio. Fitting was
achieved using the equation f=Fmin+((Fmax-Fmin)*((E+x+Kd)-
SQRT((E+x+Kd)‘2-4*E*x)))/(2*E) [21,22].
Crystallization and x-ray diffraction data collection
BmrA crystallization assays were carried out using the sitting
drop vapor diffusion method mixing equal volumes of protein and
reservoir solution. Prior to flash freezing, crystals were transferred
for 10–20 s to a 10 ml drop of reservoir solution containing 10%
(v/v) glycerol for cryo-protection. Data were collected on beamline
ID23EH-1 at the European Synchrotron Radiation Facility
(ESRF, Grenoble).
Results
Concept and design of the structuring detergents
In the late 80 s, Gunnar von Heijne established that membrane
proteins from prokaryotes to higher eukaryotes relatively display a
higher level of basic residues at the cytosol-membrane interface
[23,24], as schematized in Figure 1A. Originally validated on a
limited set of membrane proteins, this observation was later
strengthened by examining membrane proteins of more than one
hundred genomes [25]. We took advantage of this feature to
develop amphiphilic compounds able to build a network of salt
bridges with these basic residues, in close proximity to the
membrane region where such molecules accumulate upon
membrane protein extraction. In addition to the favourable
hydrophobic interactions between the hydrophobic chains of the
detergent molecules and the hydrophobic residues of the
membrane domain, this network of salt bridges is expected to
strengthen the membrane-domain packing. To test this concept,
we conceived a set of amphiphilic calix[4]arene-based constructs
Figure 1. Concept of salt bridge network between anionic and amphiphilic molecules and basic residues located at the cytosol-
membrane interface of membrane proteins. (A) Scheme of a hypothetical dimeric membrane protein typically displaying basic residues at the
cytosol-membrane interface, as established by von Heijne [24]. In the absence of lipids, the membrane domain remains in a native conformation due to
compounds displaying detergent properties for keeping the membrane protein in solution (grey molecules), but also mild-anionic groups (black
molecules), for generating a network of salt bridges close to the membrane domain with basic amino acids carried by the intracellular loops (or
domains) of the membrane proteins. (B) Chemical structure of the designed molecules, C4Cn. Three aromatic rings are substituted by a methylene
carboxyl group, -CH2COOH, at the para position. An aliphatic chain R, O(CH2)0-11CH3, is grafted onto the fourth phenolic group. The resulting 3D-
structure is modelled from the crystal structure of nitrile derivatives [26], substituting the CN groups with carboxyl groups.
doi:10.1371/journal.pone.0018036.g001
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concentrations on the surface tension of aqueous solution. The surface tension is measured as described in Methods. Each value is the mean of three
experiments 6 the standard error. C4C1, C4C3, C4C7 and C4C12 are indicated by circles, diamonds, triangles and squares, respectively. (B) Dynamic light
scatteringofC4Cninaqueoussolution.Experimentswere carriedoutas describedinMethods.Meansize valuesareindicatedinnmforthe corresponding
compound.(C)Effectof pHon thesurface tension generatedby C4C7. Experiments have been carriedoutas in (A), neutralizingC4C7 at pH 9.0, 8.0 and6.0,
and measuring the resulting surface tension by increasing the concentration of the compound, as indicated by circles, triangles and squares,
respectively. The values result from triplicate experiments. (D) Interaction of C4C7 with amino acids probed by surface tension. C4C7 diluted to 10 mMw a s
incubated with increasing concentrations of either glutamate (circles), lysine (triangles), arginine (squares) or proline (diamonds), measuring the
resulting surface tension, as described in Methods. (E) Chemical shifts of the aH and eH protons of lysine in the presence of C4C1. The
1H NMR spectra of L-
Lysine(10 mM)was recordedas describedin Methodsinthepresenceofincreasing C4C1 concentrationsas indicatedin the Figure,resultinginchemical
shifts of aH and eH protons of lysine which were plotted as a function of C4C1 concentration. (F). Dissociation of the L-lysine - C4C1 complex, each added
at 10 mM, induced by increasing the salt concentration as indicated and probed by measuring the chemical shift of lysine aH protons.
doi:10.1371/journal.pone.0018036.g002
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compounds are built on a rigid calix[4]arene backbone onto
which three acidic methylene-carboxylate groups have been
grafted at the para position while the other face bears a single
aliphatic chain CnH2n+1 varying in length from one to twelve
carbon atoms (Figure 1B). The latter allows the modulation of the
hydrophobic properties of the molecule to optimize the step of
membrane protein extraction. The overall constructs possess a
more or less elongated tetrahedral shape with three negatively-
charged summits and one hydrophobic tail, which should favour
the formation of spherical micelles [27]. They are called ‘‘C4Cn’’
in the present paper, with n=1–12.
Biophysical properties of C4Cn and interaction with basic
amino acids
C4Cn form colloidal suspensions at pH values above 5.0, and
can be used in a pH range extending from 5.5 to 14. They display
a wide range of CMC values varying from 1.5 mM for C4C3 to
0.05 mM for C4C12, with a clear but surprising rupture in the
CMC values at C4C7 (Figure 2A). As estimated from dynamic
light scattering (DLS), the micelles of C4Cn have a mean-size
diameter of 5–24 nm (Fig. 2B). These molecules being weak acids,
their CMC is sensitive to the pH, as exemplified for C4C7 in
Figure 2C, which shows that lowering the pH from 9 to 6 increases
the CMC from 0.07 mM to 0.3 mM. Such a property can be used
for modulating the micellar behaviour of these detergents. We
then followed the interaction of C4Cn with amino acids, again
illustrated with C4C7, probed as a variation of the surface tension.
As shown in Figure 2D, increasing the concentration of an anionic
amino acid such as glutamatic acid (circles) had no effect; the effect
of proline (diamonds) remained limited while that of basic amino
acids such as arginine (squares) or lysine (triangles) markedly
lowered the surface tension. This behaviour was confirmed by
1H
NMR titration experiments [28] carried out with C4C1 and lysine
(Figure 2E), which clearly shows that the signals for the eCH2
protons of lysine are strongly shifted to higher field upon
interaction with calix[4]arenes while the aH signal remains
constant. The inclusion is stabilised by the formation of a salt
bridge between the terminal NH3
+ and a carboxylate and can be
reversed by increasing the salt concentration above 0.5 M
(Figure 2F).
C4Cn successfully extract membrane proteins from
prokaryotes to higher eukaryotes
The ability of the new tri-anionic calix[4]arene-based detergents
to extract membrane proteins was demonstrated for a number of
different membrane proteins: two ABC transporters from Bacillus
subtilis expressed in E. coli, the homodimer BmrA [12] and the
heterodimer YheI/YheH [13], the human homodimeric ABC
transporter ABCG2 [29,30] expressed either in Sf9 insect cells [14]
or in human embryonic kidney HEK293 cells [15]. We also tested
membrane proteins being unrelated to ABC transporters such as
AcrB overexpressed in E. coli [31] and the naturally abundant
sarcoplasmic reticulum calcium-transporting ATPase [32]. As
shown in Figure 3A–D, compounds bearing a short aliphatic tail
such as C4C1 and C4C3 did not extract the membrane proteins
but contributed to remove contaminating proteins in the
corresponding supernatants. A break in the extraction properties
of the compounds was clearly observed from C4C7 and above, as
was seen in the physical properties of the molecules. C4C12
extracted BmrA (panel A) or ABCG2 expressed in insect cells
(panel C) with a higher efficacy than DDM and at least as well as
FC12. As shown in panel B, C4C7, C4C10 and C4C12 extracted
only 30–50% of the YheI/YheH heterodimer. A similar result was
obtained with DDM, while FC12 (or SDS, not shown) fully
extracted the heterodimer from the membrane fraction. This
arises from the fact that this heterodimer is probably non-
homogeneously overproduced in E. coli, one population of the
protein being extracted only by strong detergents. These results
also highlight that, although anionic, these compounds behave
more like mild detergents, such as DDM, than as more aggressive
detergents such as FC12 (or even stronger ones such as SDS).
Consequently, they will extract membrane proteins under mild
conditions but will likely fail to solubilize proteins from objects
such as inclusion bodies. Finally, although mainly exemplified with
ABC transporters, the extraction capacity of C4C7-12 is not
limited to these proteins as shown in panels E and F with C4C7
extracting AcrB and the SR-Ca
2+-ATPase, respectively (E and F
panels).
C4Cn allow BmrA purification and detergent exchange
Purification is a pre-requisite step and detergent exchange is
routinely carried out for subsequent membrane protein functional
studies and crystallization. The compounds were tested in such
assays. Taking advantage of the poor capacity of C4C3 to extract
BmrA (Fig. 3), we carried out a first step with that compound to
discard contaminating proteins in the resulting supernatant
(Fig. 4A, lane C4C3 S) and retain the desired protein in the
precipitate. The BmrA-enriched membrane pellet obtained with
C4C3 (lane C4C3 P) was then subjected to C4C7 extraction
allowing total extraction of BmrA (lane C4C7 S). As shown, C4Cn
could be visualized at the bottom of the SDS-PAGE (arrows), due
to their interaction with the Coomassie blue stain. This is
characteristic of the calix[n]arenes, classical detergents being not
revealed by this stain. The C4C7 supernatant, mainly containing
BmrA, displayed as shown using DLS (Fig. 4B), a population of
mixed protein-detergent micelles of 10-nm diameter (red trace) in
addition to that of C4C7 micelles centred to 5-nm diameter (black
trace). The diameter of the latter is somewhat smaller than that
estimated from Figure 2B (6.4 nm), a difference that can be
attributed to the different buffer compositions. BmrA from the
C4C7 supernatant was further purified by nickel-affinity chroma-
tography carried out in the presence of C4C7 (see [Methods] for
details), as shown in Figure 4C. The protein bound to the resin
and eluted in a single peak (star) is displayed in the corresponding
SDS-PAGE. The same C4C7 supernatant was alternatively
submitted to gel filtration chromatography carried out in the
presence of FC12 (or DDM, not shown) to allow the exchange of
C4C7 by FC12. Results are displayed in Figure 4D. As shown,
BmrA eluted at 12 ml (twin stars), an elution volume typical of a
Figure 3. Extraction of membrane proteins by C4Cn derivatives. Extraction of ABC transporters by C4Cn, prokaryotic BmrA (A) and YheI/
YheH (B) expressed in E. coli, human ABCG2 expressed in Sf9 (C) or HEK293 (D) cells, together with AcrB expressed in E. coli (E) and the SR-Ca
2+-ATPase
(F), was carried out on the corresponding membrane fractions as described in Methods. After solubilisation, extracted and non-extracted materials
were separated by high-speed centrifugation, generating a supernatant S and a pellet P which were loaded on a 10% SDS-PAGE, and after migration
either stained with Coomassie blue or submitted to a Western blot for ABCG2 (upper lanes in panels in C and D). Arrows indicate the position of each
monomer. Positive control experiments were carried out with DDM, FC12 and C12E8, negative controls were carried out without detergent (No det).
The red dotted line indicates the threshold of extraction.
doi:10.1371/journal.pone.0018036.g003
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detergent exchange could be easily checked using SDS-PAGE,
which shows a faint trace of C4C7 at the bottom of the gel, by
comparison with the SDS-PAGE done with the Ni-NTA pool
(SDS-PAGE Fig. 4C).
C4Cn preserve a functional state of BmrA during
extraction, purification and detergent exchange
The aim of this work was to synthesize detergents able to
maintain functional membrane proteins in detergent solution for
further functional and crystallization assays. We checked the
ability of the new compounds to achieve this task using BmrA. As
for all ABC transporters, BmrA displays a membrane domain and
a cytosolic domain, the former binding and transporting drugs and
the later binding and hydrolysing ATP. Transport occurs through
successive conformational changes involving a cross-talk between
cytosolic and membrane domains. Hydrolysis of ATP allows
resetting of the protein to its initial conformation after drug efflux
[33,34]. The protein in detergent solution cannot transport a drug
due to the absence of closed vesicles but it should remain able to
carry out all the steps of drug binding and release associated with
ATP hydrolysis. This ATPase activity is therefore a useful tool for
probing the functional state of ABC transporters. We used it
together with the drug-binding capacity of the transporter to
evaluate the effects of our compounds in comparison with the
effects induced by commonly-used detergents such as DDM, FC12
and also SDS as an anionic detergent. The results are displayed in
Figure 5. In a first experiment displayed in panel A, we compared
the drug-binding capacity of BmrA extracted with either FC12 or
C4C10. As C4C10 interferes with the fluorescence of tryptophan
residues, it was necessary to exchange it with FC12 after Ni-NTA
chromatography (done as shown in Figure 4). The addition of
daunorubicin, a drug previously shown to be transported by BmrA
[12], led to quenching of tryptophan fluorescence saturating at
40 mM with 15% quenching. As shown, the binding of
daunorubicin was similar for both detergents. The resulting Kd
could be estimated as 12.460.8 mM, a value statistically identical
to that found for the protein previously purified in DDM
(12.263.5 mM) [12]. This result supports the fact that the
membrane domain of BmrA remains fully functional under these
conditions.
Results were much more variable when we checked the ATPase
activity of BmrA remaining after extraction with these detergents.
As shown in Figure 5B the extraction by DDM, FC12 or SDS
under conditions used in Figure 3 resulted in a reduction of
90–99% of the ATPase activity, indicating a loss of communica-
tion between membrane and cytosolic domains and suggesting
that the protein was somehow altered and/or inhibited. In
contrast, C4C7 used under the same conditions fully extracted
BmrA and preserved up to 50% of the ATPase activity (Fig. 5B,
Extraction/C4Cn bar). Finally, we checked the ATPase activity of
the protein after extraction with C4C3+C4C7, followed by Ni-
NTA chromatography in C4C7 and gel filtration carried out with
Figure 4. BmrA purification with C4Cn and detergent ex-
change. (A) SDS-PAGE of the sequential extraction of BmrA. As
detailed in Methods, the membrane fraction (lane T) was incubated
with C4C3 and then centrifuged to give the supernatant S and the
pellet P. The latter, enriched in BmrA, was suspended in the presence of
C4C7 and then centrifuged to give the corresponding supernatant S
and pellet P. Arrows indicate the position of BmrA, C4C3 and C4C7. The
C4C7 supernatant was then subjected to DLS (B), Ni-affinity chroma-
tography (C) and gel filtration carried out with FC12 (D) from which
respective pools indicated by stars were loaded onto SDS-PAGE.
doi:10.1371/journal.pone.0018036.g004
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extract was compared to that of the protein purified using only
FC12. Strikingly, we observed that in the first case the protein
recovered 90% of ATPase activity although FC12 was present in
the last step of purification whereas when extracted and purified
with just FC12 no ATPase activity was detected. This suggests that
C4C7 remaining associated to BmrA after exchange with FC12,
(see SDS-PAGE in Figure 4D), may be sufficient to maintain
BmrA in a functional state. It should be noted that these ATPase
activities were measured 48 h after purification, using fractions
stored at 4uC, indicating that the stabilisation obtained with C4C7
is not transient.
The functional stabilisation brought about by C4Cn supposes
that this kind of detergent through hydrophobic interactions and
multiple salt bridges should have a stronger degree of interaction
with the membrane as compared to the interactions with classical
detergents. To investigate this point, we probed the interaction of
C4C10 with BmrA, extracted either with C4C10 or FC12 and
then purified in FC12 by following the intrinsic fluorescence of the
membrane protein. As shown in Figure 5C, the addition of C4C10
to the protein extracted with FC12 and purified with FC12 (circles)
led to a quenching of about 20%, obtained at a concentration of
20 mM of detergent. This corresponds to a detergent-protein ratio
of 20, BmrA being at a concentration of 1 mM in this experiment
(see legend of the Figure). In contrast, no quenching of
fluorescence was observed for the protein extracted with C4C10
and purified with FC12 (squares) suggesting that here the binding
sites of C4C10 were already saturated by this detergent during
extraction and that it remained bound to the protein during the
subsequent FC12-exchange step. This implies that C4C10
interacts specifically with the membrane domain which could
explain the functional stability of the protein in this detergent
solution.
C4Cn promote BmrA crystallization
Anionic detergents have been reported to not favour membrane
protein crystallization. Because C4Cn belong to this class, we
investigated the consequences of their use in this type of assays. In
contrast to certain ABC transporters [35,36,37], BmrA has not
been yet structurally characterised and none of them have been
structurally characterised in the presence of drugs. We are thus
trying to elucidate the 3D structure of BmrA in the presence of
drugs, and towards this end the action of C4C10 and FC12 with
regard to crystallization has been compared.
BmrA was extracted either with C4C10 followed by exchange
with FC12 as described above or directly extracted and purified
with FC12. Crystals were obtained under several conditions using
the C4C10-extracted protein, including 0.2 M KSCN, 20% PEG
3350 and 1 mM doxorubicin as displayed in Figure 6A. However,
no crystals were observed under the same conditions with BmrA
that was directly extracted and purified in FC12. This illustrates
that although anionic, C4Cn detergents may promote membrane
Figure 5. C4Cn preserve a functional state of BmrA. (A) Binding
of daunorubicin to BmrA monitored by intrinsic (Tryptophan, Trp)
fluorescence quenching. BmrA was extracted and purified either with
C4C10 (circles) or FC12 (triangles) as in Figure 4, the former being
subsequently exchanged by FC12 as in Figure 4D. The purified protein
was then incubated with increasing concentrations of daunorubicin, the
binding of the drug being probed by the variation of intrinsic
fluorescence of BmrA, as described in [Methods]. (B)V O 4-sensitive
ATPase activity of BmrA (see Methods) in different fractions: BmrA-
enriched membrane fraction (‘‘-‘‘ bar) corresponding to 0.5 mmol/
min.mg and taken as 100%; BmrA-enriched membrane fraction
solubilized with 1% SDS, FC12, DDM, or C4C3+C4C7 (‘‘Extraction/
C4Cn’’ bar, carried out as in Fig. 4); BmrA extracted with FC12 and then
purified by metal affinity and gel filtration with FC12 (‘‘Purification/
FC12’’ bar); BmrA extracted with C4C3+C4C7 and then purified by metal
affinity with C4C7 followed by detergent exchange with FC12 using gel
filtration as carried out in Figure 4 (‘‘Purification/C4Cn, FC12 exchange’’
bar). (C) Intrinsic fluorescence quenching monitoring of C4C10 binding
on BmrA. BmrA was extracted either with C4C10 or FC12 and then
purified with FC12 as in Figure 4 generating two populations on which
C4C10 binding was monitored by probing the quenching of intrinsic
fluorescence of 1 mM BmrA as detailed in Methods.
doi:10.1371/journal.pone.0018036.g005
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bound C4C10 for promoting BmrA crystallization. This hypoth-
esis is supported by the fact that the crystals displayed in Fig 6A
diffracted X-rays to 8.0 A ˚ resolution (Figure 6B).
Discussion
Structural biology of membrane proteins is still in its infancy,
being constrained by two hardly-compatible principles: the need of
lipids for structuring the membrane domain, and the imperfect
folding of proteins outside this specific environment. However, the
techniques used to date to solve their 3D-structure require
detergent-solubilized membrane proteins, except for the promising
approach of solid-state NMR, still in an early development stage
[38] and which cannot be used (to date) for solving the structure of
membrane proteins as large as BmrA (130 kDa). Amphiphilic
molecules such as detergents are thus used to make the link
between these constraints, replacing lipids around the membrane
through hydrophobic interactions and maintaining the protein in
micelles through hydrophilic interactions with the solvent.
Unfortunately, they display poor structuring properties. The
current compounds were designed to fill this gap, adding to these
classical amphiphilic properties the capacity to generate a network
of salt bridges around the protein, in close proximity to the
membrane domain with positively-charged residues located at the
membrane-cytosol interface of the protein [24]. Figure 2 shows
that the compounds reported herein indeed are amphiphilic
molecules, generating micelles (panel A) and, as expected interact
with positively-charged amino-acids (panel D). Although bearing
three negative charges, these detergents do not behave as FC12 or
SDS. Heptyl to dodecyl derivatives of C4Cn extract membrane
proteins tested here (Figure 3), in some cases partially (YheI/
YheH), behaving like mild detergents, as shown here with BmrA,
ABCG2, AcrB and the Ca
2+-transporting ATPase. An advantage
of the present set of compounds lies in the fact that the derivatives
carrying short alkyl chains can be used to enrich the fraction
containing the target protein, as shown in Figure 3 for all the
tested ABC transporters and also, more specifically, for BmrA in
Figure 4A. This behaviour allows using a limited number of trials,
optimization of the extraction step, thus avoiding the necessity to
test a large number of assays as needed for other detergents.
We have designed these detergents with the aim of stabilizing an
active conformation of the extracted membrane proteins such as
ABC transporters, and as shown in Figure 5 they indeed behave as
expected. As exemplified by C4C7 and C4C10, this new type of
detergents preserves the ATPase activity together with a drug-
binding capacity to the extracted protein. Both the extraction and
the retention of activity are better than those observed with mild
detergents such as DDM, zwitterionic and more aggressive
detergents such as FC12, or anionic and stronger detergents such
as SDS. Although rather encouraging, the decrease of 50% of
ATPase activity upon C4Cn extraction shows that these
compounds can be improved. Quite importantly, they can be
used throughout a purification process, including metal affinity
and gel filtration chromatographies, a last step allowing if required
a successful exchange with a classical detergent such as FC12
(Figure 4D), with a preservation of the protein in an active state
while the same process carried out with FC12 results in an inactive
protein. This may be due to a tight binding of C4Cn as suggested
by Fig. 5C which shows that C4Cn interact with BmrA when
extracted and remains bound to BmrA in the presence of FC12
when added in the last purification step. This small set of
compounds thus represents a powerful tool for the study of ABC
transporters but also for the extraction of other membrane
proteins, e.g. AcrB or SR Ca
2+-ATPase, as shown (Fig. 3). Last but
not the least, these new compounds, although anionic, seem to be
potentially promising in promoting the crystallization of mem-
brane proteins as seen here for BmrA. Further work will aim at
improving the quality of the crystals so as to allow determination of
the 3D-structure of this and other membrane proteins, hopefully at
a resolution high enough to identify C4Cn bound to the protein.
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Figure 6. Crystallization of BmrA extracted with C4C10. BmrA was extracted and purified as described in Figure 5, using C4C10 instead of
C4C7 and exchanging it with FC12. (A) The protein, concentrated to 10 mg/ml, and mixed with 1 mM doxorubicin, crystallized after 10 days in 0.2 M
KSCN, 20% PEG 3350, and was (B) analyzed at the ESRF beamline ID23EH-2.
doi:10.1371/journal.pone.0018036.g006
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